Ribbon Cutting Ceremony with First Lady of Virginia Marks Expansion of Health Diagnostic Laboratory, Inc. (HDL, Inc.)
For Immediate Release
January 13, 2011
Richmond, Virginia — Health Diagnostic Laboratory, Inc. (HDL, Inc.), www.myhdl.com, will host a ribbon cutting ceremony with First Lady of Virginia Maureen McDonnell to mark the official opening of its expanded headquarters at the Virginia BioTechnology Research Park on January 19, 2011 from 4:00 to 6:00 PM. The growing CAP accredited laboratory, which offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases, was launched one year ago. Experiencing rapid growth in its first year, the advanced laboratory now employs over 180 medical professionals and is continuing to hire new medical leaders to expand its talent base. Details for the ribbon cutting ceremony include:
Wednesday, January 19, 2011
4:00 to 6:00 PM
Ribbon Cutting at 4:15 PM by First Lady of Virginia Maureen McDonnell
Wine Tasting by Veritas Vineyards
Laboratory Tours
737 N 5th Street, Suite 200
Richmond, Virginia 23219
First Lady of Virginia Maureen McDonnell will welcome medical leaders, tenants of the Virginia BioTechnology Research Park, Richmond Mayor Dwight Jones, and public officials from the Commonwealth of Virginia. The ribbon cutting ceremony will also feature a presentation on the benefits of red wine from retired neurologist and owner of Veritas Vineyards, Andrew Hodson.
Cofounders of Health Diagnostic Laboratory, Tonya Mallory, CEO, and Joe McConnell, Chief Medical Officer.
Inc. said, “Our ribbon cutting ceremony is a time to celebrate not only the growth of Health Diagnostic Laboratory, but more importantly, the progress made towards the fight against cardiovascular and related diseases.”
“By using a systematic approach, the medical community can now detect the unexpected. We are truly celebrating the fact that we can now identify factors contributing to disease, and provide a better basis for effective treatment. We’re no longer confined to limited lab results, and are in a position to substantially advance the continuum of care,” said Mallory.
“We congratulate Health Diagnostic Laboratory, Inc. on their outstanding growth that has led to this ribbon cutting celebration here at the Virginia BioTechnology Research Park. We are very proud to have HDL, Inc. as part of the Park family and wish them continued success,” said Robert T. Skunda, President and CEO of the Virginia BioTechnology Research Park.
About HDL, Inc.: Health Diagnostic Laboratory Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients. As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Health Coaches at no additional cost, improving compliance and enhancing satisfaction.
Move beyond disease diagnosis; call Health Diagnostic Laboratory, Inc. at 1-877-4HDLABS (443-5227) or visit www.myhdl.com.
About the Park: The Virginia BioTechnology Research Park is currently home to a unique mix of over 66 public and private bioscience companies, research institutes affiliated with the VCU Medical Center, and major state and national medical laboratories. These companies are housed in nine buildings totaling more than 1.1 million square feet of space, representing an employee base that exceeds 2,000. The Park’s nationally recognized biosciences business incubation program, the Virginia Biosciences Development Center (VBDC), has successfully graduated more than 40 client companies, including three publicly traded firms. VBDC’s client companies and graduates have attracted more than $400 million in equity, grant and strategic capital. The Park’s Virginia Biosciences Commercialization Center (VBCC) has been created to assist international life sciences companies locating at the Park with commercialization activities through M&A or IPO, giving these Park’s tenants full-scale business assistance as they enter the US market. The Commercialization Center is working with 12 bioscience companies with technologies ranging from medical devices to diagnostics and therapeutics. www.vabiotech.com
